4.7 Article

Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death

期刊

CARDIOVASCULAR RESEARCH
卷 117, 期 3, 页码 876-889

出版社

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvaa117

关键词

Human influenza A virus; Heart infection; Viral replication; Premature death

资金

  1. European Molecular Biology Organization [STF-7649]
  2. Spanish Ministry of Science, Innovation and Universities (MCIU) [BFU2014-57797-R, BFU2017-83392-R]
  3. network Ciber de Enfermedades Respiratorias (CIBERES)
  4. Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency
  5. Severo Ochoa Center of Excellence [SEV-2015-0505]
  6. MCIU
  7. Pro CNIC Foundation
  8. Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency [MDM-2017-0720]
  9. Fondo Europeo de Desarrollo Regional [CB16/11/00458]
  10. MCIU [SAF2015-65607-R, SAF2016-80324-R]
  11. Frankel Cardiovascular Centre, Michigan Medicine [332475]
  12. National Heart, Lung, and Blood Institute [HL122352, R21HL138064, R01HL129136]
  13. [SVP-2014-068595]

向作者/读者索取更多资源

The study found that human influenza A virus can infect the mouse heart and cardiac-specific conduction system, with highly pathogenic viruses causing faster replication, higher levels of inflammatory cytokines, and higher viral titres in the heart, leading to cardiac conduction abnormalities and high mortality rates.
Aims Human influenza A virus (hIAV) infection is associated with important cardiovascular complications, although cardiac infection pathophysiology is poorly understood. We aimed to study the ability of hIAV of different pathogenicity to infect the mouse heart, and establish the relationship between the infective capacity and the associated in vivo, cellular and molecular alterations. Methods and results We evaluated lung and heart viral titres in mice infected with either one of several hIAV strains inoculated intranasally. 3D reconstructions of infected cardiac tissue were used to identify viral proteins inside mouse cardiomyocytes, Purkinje cells, and cardiac vessels. Viral replication was measured in mouse cultured cardiomyocytes. Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were used to confirm infection and study underlying molecular alterations associated with the in vivo electrophysiological phenotype. Pathogenic and attenuated hIAV strains infected and replicated in cardiomyocytes, Purkinje cells, and hiPSC-CMs. The infection was also present in cardiac endothelial cells. Remarkably, lung viral titres did not statistically correlate with viral titres in the mouse heart. The highly pathogenic human recombinant virus PAmut showed faster replication, higher level of inflammatory cytokines in cardiac tissue and higher viral titres in cardiac HL-1 mouse cells and hiPSC-CMs compared with PB2mut-attenuated virus. Correspondingly, cardiac conduction alterations were especially pronounced in PAmut-infected mice, associated with high mortality rates, compared with PB2mutinfected animals. Consistently, connexin43 and Na(V)1.5 expression decreased acutely in hiPSC-CMs infected with PAmut virus. YEM1 L protease also decreased more rapidly and to lower levels in PAmut-infected hiPSC-CMs compared with PB2mut-infected cells, consistent with mitochondrial dysfunction. Human IAV infection did not increase myocardial fibrosis at 4-day post-infection, although PAmut-infected mice showed an early increase in mRNAs expression of lysyl oxidase. Conclusion Human IAV can infect the heart and cardiac-specific conduction system, which may contribute to cardiac complications and premature death. [GRAPHICS] .

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据